The European Medicines Agency has granted orphan drug designation for ImmunoCellular Therapeutics' ICT-107 for the treatment of glioblastoma.
http://ift.tt/1co40OU
http://ift.tt/1co40OU
Healthcare Law News: News on Healthcare Law continually updated from thousands of sources monitored by the B Media Network.
No comments:
Post a Comment